Two new nitrogen-containing verticillene diterpenoids, cespilamides A and B (1 and 2), three new nitrogen-containing sesquiterpenoids, cespilamides C-E (3-5), and five new norverticillene and verticillene diterpenoids, cespitaenins A-E (6-10), were isolated from the Taiwanese soft coral Cespitularia taeniata. Compound 1 possesses an unusual oxazo ring system at C-10 while compound 2 displays an unprecedented C-C bond cleavage between C-10 and C-11 with an N-ethylphenyl group at C-10. Biogenetic pathways of 1 and 2 are proposed. The absolute configuration of 1 was confirmed by Mosher's method and molecular mechanics calculations (MM2). The cytotoxicities of compounds 1-10 were evaluated against a small panel of human cancer cell lines.
Introduction
Marine invertebrates have been proven to secrete a number of secondary metabolites for self-defense, and those marine natural products usually show unexpected bioactivities. For example, sarcodictyins isolated from Bellonella albiflora and eleutherobins obtained from Eleutherobia aurea showed significant cytotoxicities [1, 2] . Aberrarone discovered from gorgonian Pseudopterogorgia elisabethae possessed potent antibacterial effects [3] . Those compounds can benefit new drug development and also inspire drug design. Soft corals of the genus Cespitularia produce various types of terpenoids such as cembranes, neodolabellanes, cespitularanes, and verticillanes [4] [5] [6] [7] [8] . These compounds are reported to demonstrate cytotoxic and immune-modulatory activities [9] [10] [11] [12] [13] [14] . In our continuous research of Taiwanese soft corals, a series of nor-verticillenes and nitrogen-containing verticillanes from C. taeniata were isolated and reported [10, 11] . Those findings impel us to further investigate this benthos. In this paper, we describe the isolation and structural elucidation of ten new marine natural products including two nitrogen-containing verticillanes (1 and 2), three nitrogen-containing sesquiterpenes (3) (4) (5) , two norverticillanes (6 and 7), and three verticillanes (8) (9) (10) from Taiwanese soft coral C. taeniata ( Figure 1 ). 
Results and Discussion
The EtOAc-MeOH (1:1) extract of C. taeniata was partitioned between H2O and EtOAc to give an EtOAc-soluble fraction. Extensive column chromatography and HPLC purification allowed the separation of ten new compounds (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) .
Cespilamide A (1) H-1′/C-10, C-11 suggested that there is an ethylene moiety between the C-10 oxygen function and the nitrogen of the amide moiety. The configuration of compound 1 was determined by NOESY correlations and the Mosher's ester method. It was assumed that compound 1 has the same absolute configuration at C-1 as naturally-occurring verticillene diterpenoids, such as cespitulactams, cespitularines, and toxoids [10, 12, 13] . NOESY ( Figure 2 ) correlations of H-1/Me-16, Me-17 and H-7/ Me-17 indicated the β-orientation of Me-16 and Me-17. Moreover, NOESY correlations of H-6/Me-19/H-9α (δH 2.83) and H-7/H-9β (δH 2.58) suggested that H-6 is α-oriented. The configuration of the hydroxy group at C-6 was further determined by Mosher's reactions to yield products 1a and 1b. The results, illustrated in Figure 3 , suggested that C-6 has the S configuration. A computer-generated MM2 structure for compound 1 calculated for the lowest energy is illustrated in Figure 3 . The result also agreed with a S configuration at C-6. Due to lack of NOE interaction between H-7 and Me-19, the geometry of the 7,8-double bond in 1 was deduced to be E. (Figure 4 ) of H-9/C-10, C-8, H-12/C-11, Me-16/C-11, Me-17/C-11 and H-1′/C-10 permitted assignment of the two carbonyls at C-10 and C-11. Also, it established the connectivity between C-10 and C-1′. The absence of HMBC correlations between H-9/C-11, and H-12/C-10 indicated that compound 2 represents an unusual C-20 norditerpenoid [13] with bond cleavage between C-10 and C-11. The relative configuration of compound 2 was determined by NOESY experiments ( Figure 5 ) and computer-generated perspective models using the MM2 force field calculation. A NOESY correlation between Me-19 and H-6, and the lack of a correlation between Me-19 and H-7 suggested that the 7,8-double bond has an E geometry, similar to compound 1. (Tables 1 and 2 ) and DEPT NMR spectroscopic data revealed the presence of an amide carbonyl (δC 170.0), a trisubstituted olefin [ Me-14/C-10, C-1, C-9, C-5, and H-9/C-10, C-8, C-7 not only suggested the occurrence of double bonds between C-7/C-12 and C-8/C-9 but also assign the methyl group at C-10 and C-12. The presence of an α,β-unsaturated δ-lactam was inferred from the IR and HMBC spectra. Moreover, the HMBC correlations of H-1′/C-11, C-8 and H-2′/C-3′, C-4′, C-8′ indicated an amide carbonyl at C-11 and a phenylethyl side chain attached to a nitrogen atom. The relative configuration of 3 was determined on the basis of NOESY experiment and comparison with the optical rotation and NMR data of recent published compounds, taenialactams A and B, which were isolated from C. taeniata [14] . Assuming that H-5 possesses an α-orientation similar to that of taenialactams, the lack of NOESY correlation between H-5 and Me-14, suggested that Me-14 is β-oriented (Figure 7 ). were attributed to an ester and a carbonyl group, which were confirmed by the presence of the acetate (δC 170.1) and ketocarbonyl (δC 202.1). The (Figure 9 ). The two ketocarbonyls assigned at C-10 and C-12, and the hydroxyl group assigned at C-11 were deduced from the interpretation of HMBC correlations of H-9/C-10, C-11; H-13/C-12, C-11; Me-16, Me-17/C-1, C-11, C-15; OH-11 (δH 3.13, br s)/C-11, C-10, C-12. The remaining HMBC correlations of Me-16/C-15, C-1, Me-17/C-15, C-1 also indicated that compound 7 has the same 6/12 bicyclic system as compound 6. The NOESY spectrum showed correlations of H-1/Me-16, Me-17, OH-11/Me-16 indicating that the hydroxy on C-11 is β-oriented, while H-6 is α-oriented due to the correlations of H-6/Me-19/H-9α (δH 3.89) and H-7/Me-17/H-9β (δH 2.84). The lack of correlations of H-13/H-1, Me-16, Me-17 was consistent with an α-orientation of H-13. A postulated biosynthetic pathway for compounds 1 and 2 is illustrated in Scheme 1. Compound 1 is probably produced from cespitularin C [19] via intermediates a-d, involving steps of oxidation, serine transformation, lactamization, decarboxylation, hydroxylation, and dehydration. Compound 2 may be generated from the nor-verticillene a through intermediates e and f. These reactions deal with decarboxylation, cleavage of the double bond between C-10 and C-11 [19] , and phenylalanine transformation leading to an amide formation.
Four human cancer cell lines were chosen to test the in vitro cytotoxicity of compounds 1-10 (Table 3) 
Experimental Section

General Experimental Procedures
Optical rotations were obtained on a JASCO DIP-1000 polarimeter. IR spectra were recorded using a Horiba FT-720 spectrophotometer. The 
Animal Material
Cespitularia taeniata was collected in Green Island, Taiwan, in March 2004. This soft coral was identified by one of the authors (Y.-C.S.). A voucher specimen (GSC-1) has been deposited in the School of Pharmacy, National Taiwan University, Taipei, Taiwan.
Extraction and Isolation
The whole animals of C. taeniata (dried, 1.1 kg) were extracted with EtOAc and CH2Cl2 (1:1, each 1 L × 3) at room temperature and concentrated under reduced pressure to yield a crude extract. The crude extract was partitioned between H2O and EtOAc to yield an EtOAc-soluble fraction (100 g), which was chromatographed on a Si gel column (1 kg) and initially eluted with n-hexane (100%, 1 L), n-hexane/EtOAc (15:1 to 0:1, each 1 L), and finally MeOH (100%, 1 L) to give 12 fractions. Fractions six (3.1 g) and eight (1.7 g) were further separated on a Sephadex LH-20 column using CH2Cl2-MeOH (4:1) to furnish nine and five fractions (6-1~6-9, 8-1~8-5), respectively. Separation of fraction 6-5 (390 mg) was performed by a Si gel column (1.2 g) using a solvent mixture of n-hexane-CH2Cl2-MeOH (100:100:1~5:5:1) to yield six fractions (6-2-1~6-2-6). Fraction 6-5-3 (34 mg) was further purified with a NP-HPLC column (n-hexane-CH2Cl2-MeOH, 15:15:1) to give cespitaenin A (6, 2 mg). Fraction 6-5-4 (121 mg) and fraction 6-5-5 (68 mg) were separated with a NP-HPLC column (CH2Cl2-MeOH, 80:1) and then a RP-HPLC column was used (MeOH-H2O-CH3CN, 70:25:5) to yield cespitaenin C (8, 6 mg), cespitaenin D (9, 6 mg), cespilamide C (3, 5 mg) and cespitaenin E (10, 2.5 mg). Fraction 6-6 (310 mg) was purified with a NP-HPLC column (CH2Cl2-MeOH, 80:1) and with preparative TLC (n-hexane-BuOH, 12:1) to give cespilamide D (4, 9 mg). 
